These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 13325878)
21. A study of the immunity against tetanus toxin following the use of a combined typhoid-tetanus vaccine. HEGYESSY G; BOZSOKY S; SCHULEK E Br J Exp Pathol; 1956 Jun; 37(3):300-5. PubMed ID: 13342355 [No Abstract] [Full Text] [Related]
22. [Effectiveness of aerosol revaccination against tetanus in relation to the schemes and methods of primary immunization]. Egorova NB; Miroshnichenko IV; Vorontsova IV; Bikulov IM Zh Mikrobiol Epidemiol Immunobiol; 1971 Jan; 48(1):90-4. PubMed ID: 5553633 [No Abstract] [Full Text] [Related]
23. [Preventive effectiveness of IEM Gamaleya polyvaccine, tetravaccine and NIISI polyvaccine immunization]. TER-KARAPETIAN AZ Zh Mikrobiol Epidemiol Immunobiol; 1959 Jul; 30():15-9. PubMed ID: 13837447 [No Abstract] [Full Text] [Related]
24. [Tetanus and immunization with tetanus toxoid]. Minerva Med; 1956 Aug; 47(67-68):443-4. PubMed ID: 13378200 [No Abstract] [Full Text] [Related]
25. [The duration and intensity of antitoxic tetanus immunity in children inoculated with combined vaccines]. Maksimova NM; Basova NN Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):118-23. PubMed ID: 4450866 [No Abstract] [Full Text] [Related]
26. Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination. Simonsen O; Kjeldsen K; Heron I Lancet; 1984 Dec; 2(8414):1240-2. PubMed ID: 6150278 [TBL] [Abstract][Full Text] [Related]
27. [On the preparation and use of combined anti-diphtheria, anti-tetanus and anti-whooping-cough vaccines]. MIRCHAMSY H; TASLIMI H; AGHDACHI M Acta Med Iran; 1960 Jan; 3():14-44. PubMed ID: 14474433 [No Abstract] [Full Text] [Related]
28. Control of potency and the dosage of diphtheria and tetanus toxoids. GREENBERG L; BENOIT R J Am Med Assoc; 1956 Jan; 160(2):108-13. PubMed ID: 13271170 [No Abstract] [Full Text] [Related]
29. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92. Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047 [TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers. Mizuno Y; Yamamoto A; Komiya T; Takeshita N; Takahashi M J Infect Chemother; 2014 Jan; 20(1):35-7. PubMed ID: 24462422 [TBL] [Abstract][Full Text] [Related]
31. [Vaccination by quadruple vaccine (diphtheria, whooping cough, tetanus and poliomyelitis)]. BUTLER N Rev Immunol Ther Antimicrob; 1960; 24():167-72. PubMed ID: 13806505 [No Abstract] [Full Text] [Related]
32. [The permanency of the active antitetanus vaccination]. SEIBOLD M; BACHMANN H Dtsch Med Wochenschr; 1955 Aug; 80(33-34):1188-9. PubMed ID: 13261675 [No Abstract] [Full Text] [Related]
33. [Effect of leishmanial vaccinations on the dynamics of immunity to diphtheria in conditions of secondary revaccination with adsorbed pertussis-diphtheria-tetanus vaccine]. Serebriakov VA; Karakhodzhaeva S; Dzhumaev MD Med Parazitol (Mosk); 1972; 41(3):303-7. PubMed ID: 5055832 [No Abstract] [Full Text] [Related]
34. The significance of the inoculation interval in vaccination with polyvalent dysentery and combined typhoid-dysentery-tetanus vaccines. RAUSS K; KETYI I; RETHY L; JOO I Acta Microbiol Acad Sci Hung; 1959; 6():51-9. PubMed ID: 14436509 [No Abstract] [Full Text] [Related]
36. [Use of ADT-toxoid with decreased antigen content for the immunization against diphtheria and tetanus of children with contraindications to the inoculation of APDT vaccine. I. Revaccination of children with allergic reactivity]. Shabad AT; Braginskaia VP; Manvelova MA; Zybina TM; Aleksina SG Zh Mikrobiol Epidemiol Immunobiol; 1976 Jul; (7):80-5. PubMed ID: 1007746 [TBL] [Abstract][Full Text] [Related]
37. Studies on combined adsorbed poliomyelitis-DTP vaccine. Poliomyelitis antibody responses of children to primary immunization. HALONEN P; KAUHTIO J; LAMY M; LAPINLEIMU K; PENTTINEN K; PERHEENTUPA J; TAMMILEHTO R; TORNBLOM N Acta Paediatr (Stockh); 1962 Jul; 51():409-16. PubMed ID: 13903980 [No Abstract] [Full Text] [Related]
38. Studies on reactivity to chemically associated vaccine against enteric infections and tetanus (polyvaccine of the Institute of Experimental Medicine) in limited studies. MITEL'MAN SL; STAROVEROVA AG Zh Mikrobiol Epidemiol Immunobiol; 1958 Oct; 29(10):42-3. PubMed ID: 13626068 [No Abstract] [Full Text] [Related]
39. Preparation of chemically associated depot vaccine against enteric infections and tetanus. II. Immunological properties of chemically associated vaccine. GEKKER VD; IVANOVA LK; KOVALEVA NI; KASHINTSEVA NS; BLAGOVESHCHENSKII VA; KONIKOV AP; KLIUCHEVA VV; TARKHANOVA IA; MARMALEVSKAIA LIa Zh Mikrobiol Epidemiol Immunobiol; 1958 Oct; 29(10):38-42. PubMed ID: 13626067 [No Abstract] [Full Text] [Related]
40. [Guidelines for the use of antitetanus vaccination]. Ribero ML; Volpato C Boll Ist Sieroter Milan; 1980 Nov; 59(5):550-3. PubMed ID: 7248089 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]